Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 215-225 , February 2010

A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog

Received 8 December 2008 ,Revised 1 April 2009 ,Accepted 11 June 2009.

References 

  1. Adams MR, Shah RA, Janssen WGM, Morrison JH. Different modes of hippocampal plasticity in response to estrogen in young and aged female rats. Proc. Natl. Acad. Sci. U.S.A. 2001;98:8071–8076
  2. Almeida OP, Waterreus A, Spry N, Flicker L, Martins RN. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology. 2004;29:1071–1081
  3. Beck, A., Steer, R., 1993. San Antonio, TX Patent No. The Psychological Corporation.
  4. Beer TM, Bland LB, Bussiere JR, Neiss MB, Wersinger EM, Garzotto M, et al. Testosterone loss and estradiol administration modify memory in men. J. Urol. 2006;175:130–135
  5. Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science. 1978;202:631–633
  6. Benton AL, Hamsher K. Multilingual Aphasia Examination Iowa. University of Iowa Press; 1976;
  7. Bimonte HA, Denenberg VH. Estradiol facilitates performance as working memory load increases. Psychoneuroendocrinology. 1999;24:161–173
  8. Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J. Clin. Endocrinol. Metab. 1983;56:1278–1281
  9. Bussiere JR, Beer TM, Neiss MB, Janowsky JS. Androgen deprivation impairs memory in older men. Behav. Neurosci. 2005;119:1429–1437
  10. Canadian Pharmacists Association . Compendium of Pharmaceuticals and Specialties (CPS): The Canadian reference for health professionals. Toronto: Webcom Limited; 2007;
  11. Cherrier MM, Asthana S, Plymate S, Baker L, Matsumoto AM, Peskind E, et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001;57:80–88
  12. Cherrier MM, Rose AL, Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J. Urol. 2003;170:1808–1811
  13. Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Peskind ER, et al. The role of aromatization in testosterone supplementation – effects on cognition in older men. Neurology. 2005;64:290–296
  14. Cherrier, M.M., Montgomery, R., Nelson, P.S., Yu, E.Y., Higano, C.S., 2006. Prospective measurements of mood and cognition in men undergoing androgen deprivation therapy for biochemical relapse of prostate cancer. Poster presented at the 2006 Prostate Cancer Symposium.
  15. Cherrier MM, Aubin S, Higano CS. Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer. Psychooncology. 2008;18:237–247
  16. Cohen J. Statistical Power for the Behavioral Sciences. Hillsdale, NJ: Erlbaum; 1988;
  17. Dohanich GP. Gonadal steroids, learning and memory. In:  Pfaff DW,  Arnold AP,  Etgen AM,  Fahrbach SE,  Rubin RT editor. Hormones, Brain and Behavior. San Diego: Academic Press; 2002;p. 265–327
  18. Edginton TL, Jenkins V, Shilling V, Bloomfield DJ. An investigative longitudinal pilot study of the cognitive effects of reversible hormone therapy for prostate cancer. Psychooncology. 2004;13:S21–S22
  19. Ekstrom RB, French JW, Harman HH, Derman D. Kit of Factor-referenced Cognitive Tests. Princeton: Educational Testing Service; 1976;
  20. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 2002;87:589–598
  21. Ferrini RL, Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am. J. Epidemiol. 1998;147:750–754
  22. Folstein MF, Folstein SE, McHugh PR. Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189–198
  23. Furr BJA. The development of Casodex (bicalutamide): preclinical studies. Eur. Urol. 1996;29:83–95
  24. Gibbs RB. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol. Aging. 2000;21:107–116
  25. Gibbs RB. Testosterone and estradiol produce different effects on cognitive performance in male rats. Horm. Behav. 2005;48:268–277
  26. Gibbs RB, Gabor R. Estrogen and cognition: applying preclinical findings to clinical perspectives. J. Neurosci. Res. 2003;74:637–643
  27. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J. Clin. Endocrinol. Metab. 1991;73:1016–1025
  28. Green HJ, Pakenham KI, Headley BC, Yaxley J, Nicol DL, Mactaggart PN, et al. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int. 2002;90:427–432
  29. Green HJ, Pakenham KI, Headley BC, Yaxley J, Nicol DL, Mactaggart PN, et al. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU Int. 2004;93:975–979
  30. Halpern DF. Sex Differences in Cognitive Abilities. Hillsdale: Lawrence Erlbaum Associates; 1992;
  31. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J. Clin. Endocrinol. Metab. 2001;86:724–731
  32. Jenkins V, Bloomfield D, Shilling V. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study – reply. BJU Int. 2005;96:48–53
  33. Jezierski MK, Sohrabji F. Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation. Neurobiol. Aging. 2001;22:309–319
  34. Joly F, Alibhai SMH, Galica J, Park A, Yi Q-L, Wagner L, et al. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with non-metastatic prostate cancer. J. Urol. 2006;176:2443–2447
  35. Kaufman AS. Practice effects. In:  Sternberg RJ editors. Encyclopedia of Human Intelligence. New York: Macmillan Publishing Company; 1994;
  36. Kaufman J, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 2005;26:833–876
  37. Khosla S, Melton LJ, Atkinson EJ, O’Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J. Clin. Endocrinol. Metab. 1998;82:2266–2274
  38. Maki PM, Ernst M, London ED, Mordecai KL, Perschler P, Durso SC, et al. Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J. Clin. Endocrinol. Metab. 2007;92:4107–4114
  39. McEwen BS. Interactions between hormones and nerve-tissue. Sci. Am. 1976;235:48–58
  40. McEwen BS. Neural gonadal–steroid actions. Science. 1981;211:1303–1311
  41. Morales A, Lunenfeld B. International Society for the Study of the Aging Male. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. Aging Male. 2002;5:74–86
  42. Morley JE. Testosterone. Totowa: Human Press; 2000;
  43. Morley JE, Kaiser FE, Perry HM. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997;46:410–413
  44. Muller M, Aleman A, Grobbee DE, de Haan EHF, van der Schouw YT. Endogenous sex hormone levels and cognitive function in aging men – is there an optimal level?. Neurology. 2005;64:866–871
  45. Naftolin F, Ryan KJ. The metabolism of androgen in central neuroendocrine tissues. J. Steroid Biochem. 1975;6:993–997
  46. Nankin HR, Calkins JH. Decreased bioavailable testosterone in aging normal and impotent men. J. Clin. Endocrinol. Metab. 1986;63:1418–1420
  47. Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA. 2002;288:2170–2172
  48. Rosner W. Errors in measurement of plasma free testosterone. J. Clin. Endocrinol. Metab. 1997;82:2014–2015
  49. Salminen E, Portin R, Korpela J, Backman H, Parvinen LM, Helenius H, et al. Androgen deprivation and cognition in prostate cancer. Br. J. Cancer. 2003;89:971–976
  50. Salminen EK, Portin RI, Koskinen A, Helenius H, Nurmi M. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin. Cancer Res. 2004;10:7575–7582
  51. Salminen EK, Portin RI, Koskinen AI, Helenius HYM, Nurmi MY. Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Cancer. 2005;103:1381–1387
  52. Sherwin BB. Steroid hormones and cognitive functioning in aging men. J. Mol. Neurosci. 2003;20:385–393
  53. Sherwin BB, Henry JF. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front. Neuroendocrinol. 2008;29:88–113
  54. Snyder PJ. Effects of age on testicular function and consequences of testosterone treatment. J. Clin. Endocrinol. Metab. 2001;86:2369–2372
  55. Sodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J. Steroid Biochem. 1982;16:801–810
  56. Taxel P, Stevens MC, Trahiotis M, Zimmerman J, Kaplan RF. The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer. J. Am. Geriatr. Soc. 2004;52:269–273
  57. Thilers PP, MacDonald SWS, Herlitz A. The association between endogenous free testosterone and cognitive performance: a population-based study in 35 to 90 year-old men and women. Psychoneuroendocrinology. 2006;31:565–576
  58. Van den Beld AW, de Jong FH, Grobbee DE, Pols HAP, Lamberts SWJ. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J. Clin. Endocrinol. Metab. 2000;85:3276–3282
  59. Vandenberg SG, Kuse AR. Mental rotations, a group test of three-dimensional spatial visualization. Percept. Mot. Skills. 1978;47:599–604
  60. Vermeulen A. Androgen replacement therapy in the aging male: a critical evaluation. J. Clin. Endocrinol. Metab. 2001;86:2380–2390
  61. Vermeulen A, Kaufman JM, Goemaere S, Van Pottelberg I. Estradiol in elderly men. Aging Male. 2003;5:98–102
  62. Wechsler DA. Wechsler Adult Intelligence Scale. third edition. San Antonio: The Psychological Corporation; 1997;
  63. Wechsler DA. Wechsler Memory Scale-Revised Manual. San Antonio: The Psychological Corporation; 1987;
  64. Yonker JE, Eriksson E, Nilsson LG, Herlitz A. Negative association of testosterone on spatial visualization in 35 to 80 year old men. Cortex. 2006;42:376–386

PII: S0306-4530(09)00197-8

doi: 10.1016/j.psyneuen.2009.06.012

Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 215-225 , February 2010

Article Tools

* Image Usage & Resolution